These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment. Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124 [TBL] [Abstract][Full Text] [Related]
28. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials. Leiderman DB Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475 [TBL] [Abstract][Full Text] [Related]
29. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. Korn-Merker E; Borusiak P; Boenigk HE Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603 [TBL] [Abstract][Full Text] [Related]
30. Double-blind study of Gabapentin in the treatment of partial seizures. Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907 [TBL] [Abstract][Full Text] [Related]
31. [Clinical studies on gabapentin in Switzerland]. Shokry A Praxis (Bern 1994); 1996 Jan; 85(4):94-8. PubMed ID: 8578060 [TBL] [Abstract][Full Text] [Related]
32. Gabapentin in partial epilepsy. UK Gabapentin Study Group. Lancet; 1990 May; 335(8698):1114-7. PubMed ID: 1971862 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV)]. Rajna P; Szíjártó E Ideggyogy Sz; 2006 Sep; 59(9-10):361-72. PubMed ID: 17165379 [TBL] [Abstract][Full Text] [Related]
34. [Gabapentin in 50 patients with epilepsy]. Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098 [TBL] [Abstract][Full Text] [Related]
35. Rapid initiation of gabapentin: a randomized, controlled trial. Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308 [TBL] [Abstract][Full Text] [Related]
36. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study. Mayer T; Schütte W; Wolf P; Elger CE Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232 [TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United States with three novel drugs. French JA Epilepsia; 1996; 37 Suppl 2():S23-S26. PubMed ID: 8641243 [TBL] [Abstract][Full Text] [Related]
39. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Sethi A; Chandra D; Puri V; Mallika V Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470 [TBL] [Abstract][Full Text] [Related]
40. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Baulac M; Cavalcanti D; Semah F; Arzimanoglou A; Portal JJ Seizure; 1998 Feb; 7(1):55-62. PubMed ID: 9548227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]